XML 44 R33.htm IDEA: XBRL DOCUMENT v3.19.1
Merger with C3J Therapeutics (Details) - USD ($)
$ / shares in Units, $ in Millions
Jan. 03, 2019
Feb. 05, 2019
C3J [Member]    
Subsequent Event [Line Items]    
Anticipated purchase of common shares upon completion of merger   $ 10.0
Agreement and Plan of Merger and Reorganization [Member] | C3J [Member]    
Subsequent Event [Line Items]    
Number of shares issued per common stock outstanding 0.6892  
Percentage of ownership 70.00%  
Numerator for determination of per share price of Share Purchase Agreement   $ 40.0
Agreement and Plan of Merger and Reorganization [Member] | Ampliphi Biosciences Corp [Member]    
Subsequent Event [Line Items]    
Percentage of ownership 30.00%  
Agreement and Plan of Merger and Reorganization [Member] | Minimum [Member]    
Subsequent Event [Line Items]    
Reverse stock split ratio 0.33  
Agreement and Plan of Merger and Reorganization [Member] | Maximum [Member] | C3J [Member]    
Subsequent Event [Line Items]    
Reverse stock split ratio 0.05  
Scenario, Plan [Member] | Agreement and Plan of Merger and Reorganization [Member]    
Subsequent Event [Line Items]    
Expected price per share of combined entity   $ 0.36